Poonawalla Fincorp sells controlling stake in housing finance arm to Singapore company for Rs 3,004 crore

July 26, 2023

The Cyrus Poonawalla Group, more known for its vaccine-making business under the Serum Institute, in a statement said the financial consideration of Rs 3,004 crore is excluding the tax outgoes. With this sale, Poonawalla Housing Finance will cease to be a subsidiary of Poonawalla Fincorp, and Perseus will be holding a controlling stake.

More To Explore

Arkade Developers listing: After a bumper IPO response, GMP signals a strong debut on Tuesday

Shares of Arkade Developers have been heavily subscribed, over 100 times, and are set to debut on the exchanges on Tuesday. Ahead of the listing,

September 23, 2024

Reliance Power board approves preferential issue worth Rs 1,525 crore

Reliance Power’s board has approved issuing up to 46.20 crore equity shares/warrants worth Rs 1,525 crore via preferential allotment at Rs 33 per share. The

September 23, 2024

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information.

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003